ELITE PHARMACEUTICALS INC /NV/ Annual Income Tax Expense (Benefit) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2023.
  • Elite Pharmaceuticals Inc /Nv/ Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $239K.
  • Elite Pharmaceuticals Inc /Nv/ annual Income Tax Expense (Benefit) for 2023 was -$19.6M.
  • Elite Pharmaceuticals Inc /Nv/ annual Income Tax Expense (Benefit) for 2022 was $424K.
  • Elite Pharmaceuticals Inc /Nv/ annual Income Tax Expense (Benefit) for 2021 was -$1.74M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$19.6M* -$20.1M Apr 1, 2023 Mar 31, 2024 10-K 2024-07-01
2022 $424K +$2.16M Apr 1, 2022 Mar 31, 2023 10-K 2024-07-01
2021 -$1.74M* Apr 1, 2021 Mar 31, 2022 10-K 2023-06-29
2018 -$676K +$370K +35.4% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 -$1.05M +$822K Apr 1, 2017 Mar 31, 2018 10-K 2019-06-21
2016 -$1.87M* -$1.35M Apr 1, 2016 Mar 31, 2017 10-K 2018-06-14
2015 -$520K -$517K -15919% Apr 1, 2015 Mar 31, 2016 10-K 2018-06-14
2014 -$3.25K +$289K +98.9% Apr 1, 2014 Mar 31, 2015 10-K 2017-06-14
2013 -$293K Apr 1, 2013 Mar 31, 2014 10-K 2016-06-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.